Shunt surgery and lecanemab therapy in patients with idiopathic normal pressure hydrocephalus and alzheimer’s disease: a report of two cases - Top-Institutions - MDSpire

Shunt surgery and lecanemab therapy in patients with idiopathic normal pressure hydrocephalus and alzheimer’s disease: a report of two cases

  • By

  • Koichi Miyazaki

  • Hiroya Morita

  • Kazunari Ishii

  • February 23, 2026

  • 0 min

Share

Top Institutions in Surgery

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Neurology
    • Neurosurgery
    • Neurodegenerative Diseases

  • #2

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Neurology
    • Neurosurgery
    • Alzheimer's Disease Research

  • #3

    Massachusetts General Hospital (MGH)
    Massachusetts General Hospital (MGH)

    Boston, MA

    Key Differentiators

    • Neurology
    • Neurosurgery
    • Neurodegenerative Disease Clinical Trials

  • #4

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Neurology
    • Neurosurgery
    • Neurodegenerative Disorders

Original Source(s)

Shunt surgery and lecanemab therapy in patients with idiopathic normal pressure hydrocephalus and alzheimer’s disease: a report of two cases

  • by Koichi Miyazaki, Hiroya Morita, Kazunari Ishii

  • February 23, 2026

Related Content

The Cortical Asymmetry Index for subtyping dementia patients

The duality of disease: the Alzheimer’s disease dilemma through the lens of nosos and asthenia

Wearable EEG devices in the detection of mild cognitive impairment: a systematic review